Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.66 +2.55 (+1.68%)
Official Closing Price Updated: 7:00 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,481,935
Open 152.26
Bid (Size) 154.52 (5)
Ask (Size) 154.66 (5)
Prev. Close 152.11
Today's Range 151.92 - 155.14
52wk Range 144.95 - 181.04
Shares Outstanding 2,628,679,824
Dividend Yield 3.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company's Covid-19 
Via Talk Markets
Topics Lawsuit
Exposures COVID-19 Financial Legal
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
From Johnson & Johnson
Via Business Wire

Performance

YTD
-13.21%
-13.21%
1 Month
+4.26%
+4.26%
3 Month
-4.34%
-4.34%
6 Month
+0.08%
+0.08%
1 Year
-13.11%
-13.11%

More News

Read More
7 Blue-Chip Stocks to Buy for 2024, According to AI
Via InvestorPlace
Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns
Via InvestorPlace
This Is What Whales Are Betting On Johnson & Johnson
Via Benzinga
Is NYSE:JNJ suited for dividend investing?
Via Chartmill
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
Via InvestorPlace
Topics ETFs Initial Public Offering
Exposures Securities Market
Johnson & Johnson MedTech Acquires Laminar, Inc.
From Johnson & Johnson MedTech
Via Business Wire
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
Via Benzinga
Exposures Product Safety
The 7 Biggest Dividend Stocks in Warren Buffett’s Portfolio
Via InvestorPlace
J&J, Gilead, BMS: A look at undervalued dividend payers
Via MarketBeat
2023's most anticipated IPOs weren't always the big winners
Via MarketBeat
Topics ETFs Initial Public Offering Stocks
Exposures Securities Market US Equities
Daily Wear Contact Lenses Market May See a Big Move: Major Giants Alcon, Hydron, Lagado Corporation, Metro Optics, Johnson & Johnson Vision Care
Via SBWire
Teva Pharma is the way to play the re-rise of generic drugs
Via MarketBeat
2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now
Via The Motley Fool
Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering
Via Benzinga
3 Robotics Stocks That Could Be Multibaggers in the Making
Via InvestorPlace
The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold)
Via InvestorPlace
5 Stocks You Can Confidently Invest $500 In Right Now
Via The Motley Fool
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
Via The Motley Fool
Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?
Via The Motley Fool
Warren Buffett-Led Berkshire Hathaway Sells Its Entire Procter & Gamble Stake. Should You?
Via The Motley Fool
Heart Failure Drugs Market Critical Analysis with Expert Opinion : Johnson & Johnson, Pfizer, Roche
Via SBWire
3 Dividend Stocks You Can Safely Hold for Decades
Via The Motley Fool
Skin Tightening Products Market to Witness Massive Growth by 2029 : L'Oréal, Johnson & Johnson, Amway
Via SBWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.